SCHEMBL23225638

SCHEMBL23225638

CCOC(=O)N(C)CC1CCC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.40
BCHE P06276 2/20 0.36
ACHE P22303 1/20 0.36
MAPT P10636 1/20 0.36
ABCB11 O95342 2/20 0.35
SLCO1B1 Q9Y6L6 2/20 0.35
ABCC3 O15438 1/20 0.35
ABCC4 O15439 1/20 0.35
LPAR1 Q92633 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
ALDH1A1 P00352 2/20 0.33
TSHR P16473 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20794153 0.92 MAPT (0.38) ALOX5BCHEACHEMAPTCA12
SCHEMBL20794083 0.83 PTGIR (0.36) BCHEACHEMAPTCA12CA1
SCHEMBL27372527 0.82 SIGMAR1 (0.37) BCHEACHEMAPT
SCHEMBL25692128 0.81 ALOX5 (0.42) ALOX5BCHEACHEALDH1A1SLC6A2
SCHEMBL24131732 0.81 RAB9A (0.38) ALOX5BCHEACHEABCB11SLCO1B1
SCHEMBL24439634 0.81 ALOX5 (0.37) ALOX5BCHEACHEABCB11SLCO1B1
SCHEMBL24439477 0.80 MEN1 (0.34) MAPTCA12CA1CA2CA9
SCHEMBL12987797 0.79 ALOX5 (0.41) ALOX5BCHEACHE
SCHEMBL24287957 0.78 CHRNB2 (0.37) ALOX5BCHEACHEALDH1A1
SCHEMBL24438464 0.76 ALOX5 (0.39) ALOX5SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022100624-A1 OXY-SUBSTITUTED AMINOCARBONATE THIOPHENE-BASED COMPOUND AND USE THEREOF 武汉人福创新药物研发中心有限公司 2022-05-19 WO disclosed
WO-2021072140-A1 PRODRUGS OF MYELOPEROXIDASE INHIBITORS BIOHAVEN THERAPEUTICS LTD. (US) 2021-04-15 WO disclosed